-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Adaptive Biotechnologies Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
- Adaptive Biotechnologies Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.6M, a 36% increase year-over-year.
- Adaptive Biotechnologies Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$200M, a 2.37% decline year-over-year.
- Adaptive Biotechnologies Corp annual Operating Income (Loss) for 2023 was -$227M, a 13.4% decline from 2022.
- Adaptive Biotechnologies Corp annual Operating Income (Loss) for 2022 was -$200M, a 4.2% increase from 2021.
- Adaptive Biotechnologies Corp annual Operating Income (Loss) for 2021 was -$209M, a 36.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)